Description: Recordati Industria Chimica e Farmaceutica S.p.A. engages in the research, development, manufacture, marketing, and sale of pharmaceuticals. The company offers pharmaceuticals in various therapeutic areas, including cosmetics, dermatology, dietary supplements, gynecology and obstetrics, musculo-skeletal disorders and analgesia, over the counter/non-prescription pharmaceuticals, urology, allergy, anti-infective, cardiovascular, central nervous system, endocrinology, gastrointestinal, nutrition and related areas, immunosuppressants, pain management/inflammation, generics, pneumology, antipyretics and cold preparations, endocrinology, oncology, respiratory, medical devices, and radio contrast agent, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as active pharmaceutical ingredients and intermediates. The company operates in Europe, the Americas, Australasia, and Africa. The company was founded in 1926 and is headquartered in Milan, Italy.
Home Page: www.recordati.com
1, Via Matteo Civitali
Milan,
MI
20148
Italy
Phone:
39 02 487871
Officers
| Name | Title |
|---|---|
| Dr. Robert Koremans M.D. | CEO & Director |
| Ms. Cathrin Petty | Exec. Director |
| Mr. Giampiero Mazza | Exec. Director |
| Mr. Giorgio De Palma | Exec. Director |
| Mr. Luigi Felice La Corte | Group CFO & Exec. Director |
| Ms. Federica De Medici | Director of Investor Relations & Corp. Communications |
| Ms. Daria Ghidoni | Group Gen. Counsel |
| Mr. Giovanni Minora | Group Audit & Compliance |
| Mr. Gabriele Finzi | Exec. VP of Corp. Devel. & Licensing |
| Mr. Giuseppe Gualazzini | Sr. VP of Group HR |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 15.4083 |
|---|---|
| Trailing PE: | 24.2189 |
| Price-to-Book MRQ: | 4.8932 |
| Price-to-Sales TTM: | 5.0372 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 4300 |